PDT Partners LLC Purchases 1,997 Shares of Molina Healthcare, Inc. (NYSE:MOH)

PDT Partners LLC increased its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 124.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 3,600 shares of the company's stock after purchasing an additional 1,997 shares during the period. PDT Partners LLC's holdings in Molina Healthcare were worth $1,048,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in MOH. Norges Bank acquired a new position in Molina Healthcare during the 4th quarter valued at $134,675,000. FMR LLC increased its holdings in shares of Molina Healthcare by 31.1% during the 4th quarter. FMR LLC now owns 1,801,113 shares of the company's stock worth $524,214,000 after purchasing an additional 427,276 shares during the period. Invesco Ltd. raised its position in shares of Molina Healthcare by 28.5% during the fourth quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock valued at $386,229,000 after buying an additional 294,180 shares during the last quarter. Wellington Management Group LLP lifted its stake in shares of Molina Healthcare by 7.4% in the fourth quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock valued at $766,111,000 after buying an additional 181,073 shares during the period. Finally, Los Angeles Capital Management LLC grew its position in Molina Healthcare by 166.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 196,513 shares of the company's stock worth $57,195,000 after buying an additional 122,674 shares in the last quarter. Institutional investors own 98.50% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on MOH. Stephens reiterated an "equal weight" rating and issued a $345.00 price objective on shares of Molina Healthcare in a research report on Thursday, February 6th. Guggenheim began coverage on shares of Molina Healthcare in a research note on Wednesday, April 9th. They set a "neutral" rating on the stock. Robert W. Baird restated a "neutral" rating and issued a $375.00 price objective (up previously from $331.00) on shares of Molina Healthcare in a research note on Tuesday, April 15th. StockNews.com upgraded shares of Molina Healthcare from a "hold" rating to a "buy" rating in a research report on Friday, April 11th. Finally, UBS Group dropped their price target on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research report on Friday, February 7th. Nine equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $365.38.

Insider Buying and Selling at Molina Healthcare

In related news, CEO Joseph M. Zubretsky sold 87,500 shares of Molina Healthcare stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total value of $28,005,250.00. Following the completion of the sale, the chief executive officer now directly owns 257,715 shares in the company, valued at $82,484,262.90. This trade represents a 25.35 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard M. Schapiro sold 669 shares of the company's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the transaction, the director now owns 11,244 shares in the company, valued at approximately $3,603,702. The trade was a 5.62 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 89,169 shares of company stock worth $28,520,995. Insiders own 1.10% of the company's stock.

Molina Healthcare Price Performance

Shares of NYSE:MOH traded down $1.72 during midday trading on Tuesday, reaching $317.92. The company's stock had a trading volume of 92,182 shares, compared to its average volume of 675,696. The business's fifty day simple moving average is $322.95 and its 200-day simple moving average is $307.51. The company has a market capitalization of $17.23 billion, a P/E ratio of 15.54, a P/E/G ratio of 1.06 and a beta of 0.63. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62. Molina Healthcare, Inc. has a fifty-two week low of $262.32 and a fifty-two week high of $365.23.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. The company had revenue of $11.15 billion during the quarter, compared to the consensus estimate of $10.86 billion. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The company's revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the firm posted $5.73 earnings per share. As a group, equities research analysts expect that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.